Comparison of Efficacy of Epidural Ropivacaine versus Bupivacaine for Postoperative Pain Relief in Patients Undergoing Infraumbilical Surgeries
Vergleich der Wirksamkeit von epiduralem Ropivacain versus Bupivacain zur postoperativen Schmerzlinderung bei Patient:innen mit infraumbilikalen Operationen
Annals of African Medicine · 02.11.2026
DOI: 10.4103/aam.aam_270_26 ↗Auf einen Blick
Bei 90 Patient:innen mit infraumbilikalen Operationen verlängerte Bupivacain die postoperative Analgesie gegenüber Ropivacain. Frühe VAS-Werte waren unter Ropivacain höher.
Fragestellung
Vergleich der Wirksamkeit und Sicherheit von epiduralem Bupivacain 0,125 % versus Ropivacain 0,2 % zur postoperativen Analgesie nach infraumbilikalen Operationen.
Methode
Prospektive randomisierte Studie mit 90 Patient:innen unter Spinalanästhesie; 45 erhielten Bupivacain 0,125 % und 45 Ropivacain 0,2 % als epidurale Infusion; Beobachtung über 12 h.
Ergebnisse
VAS-Werte waren in der 3. und 4. postoperativen Stunde in der Ropivacain-Gruppe höher. Die Zeit bis zur ersten Rescue-Analgesie war in der Bupivacain-Gruppe länger; die Zahl der Rescue-Analgetika war vergleichbar.
Schlussfolgerung der Autor:innen
Epidurales Bupivacain bietet eine längere postoperative Analgesie mit besserer früher Schmerzkontrolle, während Ropivacain ein günstiges Sicherheitsprofil mit weniger motorischer Blockade und akzeptabler hämodynamischer Stabilität aufweist.
Kernaussagen
- 90 Patient:innen, randomisiert in 2 Gruppen
- Bupivacain: längere Zeit bis zur ersten Rescue-Analgesie
- Unerwünschte Ereignisse in beiden Gruppen ähnlich
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, online erschienen am 02.11.2026. Verfasst von M Rasika Priya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (DU), Sal….
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Effective postoperative pain control is a cornerstone of enhanced recovery after surgery, facilitating early ambulation, reducing complications, and improving patient satisfaction. Epidural analgesia remains a widely used and reliable technique for postoperative pain management following infraumbilical surgeries. Bupivacaine has long been considered a standard agent for epidural infusion; however, concerns regarding cardiotoxicity and motor blockade have prompted interest in ropivacaine, which is associated with a more favorable safety profile. This study was designed to compare the efficacy and safety of epidural bupivacaine 0.125% and ropivacaine 0.2% for postoperative analgesia. Materials and Methods: This prospective randomized study included 90 patients aged 18–70 years with American Society of Anesthesiologists physical status I and II undergoing infraumbilical surgeries under spinal anesthesia. Patients were randomly allocated into two groups of 45 each. Group B received epidural infusion of 0.125% bupivacaine at 6 ml/h, and Group R received epidural infusion of 0.2% ropivacaine at 6 ml/h. Postoperative pain was assessed using the Visual Analog Scale (VAS). Hemodynamic parameters, time to first rescue analgesia, total number of rescue analgesics required, and adverse effects were recorded over a 12-h postoperative period.
Results
VAS scores showed a significant difference at the 3 rd and 4 th postoperative hours, with higher pain scores observed in the ropivacaine group. The mean time to first rescue analgesia was significantly longer in the bupivacaine group compared with the ropivacaine group. The total number of rescue analgesics required during the observation period was comparable between the two groups. Hemodynamic parameters, including heart rate and blood pressure, were significantly higher in the ropivacaine group during the initial postoperative hours, although these differences were transient. The incidence of adverse effects such as hypotension, nausea, vomiting, and bradycardia was similar in both groups.
Conclusion
Epidural bupivacaine provides a longer duration of postoperative analgesia with better early pain control, whereas ropivacaine offers a favorable safety profile with less motor blockade and acceptable hemodynamic stability. Ropivacaine may be considered a suitable alternative to bupivacaine for postoperative epidural analgesia in patients undergoing infraumbilical surgeries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (DU), Salem, Tamil Nadu, India.
- Anaesthesia and Critical Care Unit, Bharathirajaa Hospital and Research Centre Pvt. Ltd., Chennai, Tamil Nadu, India.
Zitieren
APA
Priya, M. R., Tamilarasan, S., Roshan, G. P., Brindha, R., & Marappan, S. (2026). Comparison of Efficacy of Epidural Ropivacaine versus Bupivacaine for Postoperative Pain Relief in Patients Undergoing Infraumbilical Surgeries. Annals of African Medicine. https://doi.org/10.4103/aam.aam_270_26
Vancouver
Priya MR, Tamilarasan S, Roshan GP, Brindha R, Marappan S. Comparison of Efficacy of Epidural Ropivacaine versus Bupivacaine for Postoperative Pain Relief in Patients Undergoing Infraumbilical Surgeries. Annals of African Medicine. 2026. doi:10.4103/aam.aam_270_26
BibTeX
@article{Priya2026,
author = {Priya, M Rasika and Tamilarasan, Sankami and Roshan, G Pramodh and Brindha, R and Marappan, Senthil},
title = {Comparison of Efficacy of Epidural Ropivacaine versus Bupivacaine for Postoperative Pain Relief in Patients Undergoing Infraumbilical Surgeries},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_270_26}
}
EUVIMED